# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-06T13:14:24.232525
**Route:** OpenRouter + LaTeX
**Paper Hash:** 74e3a7029c0eed10
**Tokens:** 19665 in / 2350 out
**Response SHA256:** 6a185c31fee9b164

---

I checked the draft only for fatal errors in the four requested categories.

Findings:

- **Data-design alignment:** No fatal mismatch detected.
  - The main treatment is post-2022 / 2023+, and the OEWS data run through **2024**, so post-treatment observations exist.
  - The QCEW specification uses data through **2024Q4**, so post-treatment quarters also exist there.
  - Reported sample sizes are internally plausible:
    - 25 industries × 10 years = **250** in Tables \ref{tab:main} and \ref{tab:additional} cols. (1)–(2)
    - 25 × 3 × 10 = **750** in Table \ref{tab:ddd}
    - 200 nonempty cells × 10 years = **2,000** in Table \ref{tab:additional} col. (4)
    - Placebo sample 2015–2022: 25 × 8 = **200** in Table \ref{tab:robustness}, R1

- **Regression sanity:** No fatal regression-output problems detected.
  - No impossible values (no negative SEs, no R² outside [0,1], no NA/NaN/Inf in regression tables).
  - All reported coefficients and SEs are numerically plausible for the stated outcomes.
  - No coefficient/SE combinations suggesting obvious collinearity blowups.

- **Completeness:** No fatal incompleteness in the empirical tables/results.
  - Regression tables report **standard errors** and **N**.
  - Referenced tables/figures cited in the text appear to exist in the source.
  - No TBD/TODO/XXX/NA placeholders in tables.

- **Internal consistency:** No fatal contradiction detected that makes the results unusable.
  - Main text numbers for the key DiD estimates match the reported table entries.
  - Timing definitions are broadly consistent across the paper.
  - The paper explicitly acknowledges the pre-trend problem rather than silently ignoring it, so this is not an internal-consistency failure.

Caution that is **not** a fatal-error finding:
- The paper’s own event study and placebo test undermine a clean causal interpretation of post-2022 “generative AI” effects. But the draft openly states that limitation and refrains from a clean causal claim, so this is **not** a fatal advisor-stop issue under your criteria.

ADVISOR VERDICT: PASS